reports
Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics,...
Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc. Name Change Reflects Company’s Focus on Neurology, Orphan and Specialty Businesses LAKE FOREST, Ill., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, has announced that its corporate name change from “Depomed, Inc.” to “Assertio Therapeutics, Inc.” became effective at 11:59 p.m. ET yesterday, August 14, 2018. In connection with the name change, the Company’s common stock will begin trading under a new ti...
- Dave Nicoski
- Ross LaDuke
VER VEREIT INC.
ATNI ATN INTERNATIONAL INC.
TBPH THERAVANCE BIOPHARMA INC
SUP SUPERIOR INDUSTRIES INTERNATIONAL INC.
SSYS STRATASYS LTD.
SNF DIVERSIFIED HEALTHCARE TRUST
SRN SPRINT CORP.
PAA PLAINS ALL AMERICAN PIPELINE L.P.
OFC CORPORATE OFFICE PROPERTIES TRUST
NUVA NUVASIVE INC.
NTRI NUTRISYSTEM INC.
MRCY MERCURY SYSTEMS INC.
LQDT LIQUIDITY SERVICES
LB7 LIBBEY INC.
KMB KIMBERLY-CLARK CORPORATION
HTA HEALTHCARE TRUST OF AMERICA INC. CLASS A
HR HEALTHCARE REALTY TRUST INCORPORATED
HCP HEALTHPEAK PROPERTIES INC.
DORM DORMAN PRODUCTS INC.
DOC PHYSICIANS REALTY TRUST
DKS DICK'S SPORTING GOODS INC.
DEPO DEPOMED INC.
CLFD CLEARFIELD INC.
CHRS COHERUS BIOSCIENCES INC.
A2AM8Y CARDTRONICS PLC CLASS A
BXP BOSTON PROPERTIES INC.
BRX BRIXMOR PROPERTY GROUP INC.
APOG APOGEE ENTERPRISES INC.
APA.. APA CORP.
ANDE ANDERSONS INC.
DRQ DRIL-QUIP INC.
FI FRANK'S INTERNATIONAL NV
KMI KINDER MORGAN INC CLASS P
VSI VITAMIN SHOPPE
TYIA JOHNSON CONTROLS INTERNATIONAL PLC
HWKN HAWKINS INC.
BELFB BEL FUSE INC. CL B
CLPR CLIPPER REALTY
EXPRESS TRANSPORT S.A.
Depomed Announces Second-Quarter 2018 Financial Results
Depomed Announces Second-Quarter 2018 Financial Results -- Raises Full-Year Earnings and Adjusted EBITDA Guidance Range and Lowers Full-Year Net Sales Guidance Range for the Neurology Franchise -- -- Confirms Regulatory Plan to File for FDA Approval of Cosyntropin Depot by Year End -- -- Announces Agreement with PDL BioPharma to Monetize Royalty Stream; Company Received $20 Million in Cash -- -- Announces Planned Change in Company Name from Depomed to Assertio Therapeutics;Remains On-Track to Transition to New Corporate Headquarters in Lake Forest, Illinois -- LAKE FOREST, Ill., Aug. 0...
- Dave Nicoski
- Ross LaDuke
TTSH TILE SHOP HOLDINGS INC.
SCG SCANA CORPORATION
REGN REGENERON PHARMACEUTICALS INC.
O REALTY INCOME CORPORATION
NTCT NETSCOUT SYSTEMS INC.
LQDT LIQUIDITY SERVICES
LOCO EL POLLO LOCO HOLDINGS INC
KN KNOWLES CORP.
K KELLOGG COMPANY
HSIC HENRY SCHEIN INC.
GPC GENUINE PARTS COMPANY
DEPO DEPOMED INC.
CHRS COHERUS BIOSCIENCES INC.
BRX BRIXMOR PROPERTY GROUP INC.
APA.. APA CORP.
AGNN ALLERGAN PLC
AGO ASSURED GUARANTY LTD.
FI FRANK'S INTERNATIONAL NV
MAT MATTEL INC.
TCO TAUBMAN CENTERS INC.
WMB WILLIAMS COMPANIES INC.
DFIN DONNELLEY FINANCIAL SOLUTIONS INC.
HWKN HAWKINS INC.
SVU SUPERVALU INC.
Depomed to Report Second-Quarter 2018 Financial Results on Wednesday, ...
Depomed to Report Second-Quarter 2018 Financial Results on Wednesday, August 8, 2018 LAKE FOREST, Ill., July 09, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second-quarter 2018 financial results on Wednesday, August 8, 2018, before the open of markets. Following the announcement, the Company will host a conference call beginning at 8:30 a.m. ET to discuss its results. Participants can access the live webcast from the Investor Relations section of Depomed's website at . Please access the website 15 minutes prior to the start of the call to dow...
Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) LAKE FOREST, Ill., July 06, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced that effective July 3, 2018, the Company granted ten newly-hired employees a total of 512,439 restricted stock units (“RSUs”). The RSUs were granted as inducements material to each such individual’s entry into employment with Depomed in accordance with NASDAQ Listing Rule 5635(c)(4). The RSUs are subject to such employee’s continued service relationship with the Company, the terms and conditions of the Company's 2014 Omnibus In...
Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) LAKE FOREST, Ill., June 07, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced that the Company will grant Phillip B. Donenberg, the Company’s new Chief Financial Officer and Senior Vice President, 87,163 restricted stock units (“RSUs”) and 87,163 target performance stock units (“PSUs”), in each case effective upon the commencement of his employment with the Company on July 16, 2018. The RSUs and PSUs will be granted as inducements material to Mr. Donenberg’s entry into employment with Depomed in accordance...
Depomed Announces the Appointment of Phillip B. Donenberg as Chief Fin...
Depomed Announces the Appointment of Phillip B. Donenberg as Chief Financial Officer LAKE FOREST, Ill., June 05, 2018 (GLOBE NEWSWIRE) -- Lake Forest, Illinois, June 5, 2018 - Depomed, Inc. (NASDAQ:DEPO) today announced that it has appointed Phillip B. Donenberg as Chief Financial Officer and Senior Vice President, effective July 16, 2018. Mr. Donenberg will succeed August J. Moretti who has served as Depomed’s Chief Financial Officer since January 2012. Mr. Moretti will remain CFO through the transition until July 16, 2018, at which time he intends to seek another position in the San Fra...
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the C...
LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the October 17, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Depomed, Inc. (“Depomed” or the “Company”) (NASDAQ: DEPO) securities between February 26, 2015 and August 7, 2017, inclusive (the “Class Period”). Depomed investors have until October 17, 2017 to file a lead plaintiff motion. To obtain information or participate in the class action, please visit the Depomed case page ...
Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 17th L...
NEW YORK--(BUSINESS WIRE)-- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, reminds investors that October 17, 2017, is the deadline to move for lead plaintiff status in the securities class action pending against Depomed, Inc. (“Depomed” or the “Company”) (NASDAQ: DEPO). If you purchased Depomed shares between February 26, 2015 and August 7, 2017, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information. Depomed is a spe...
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Laws...
NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Depomed, Inc. (NASDAQ:DEPO) securities between February 26, 2015 and August 7, 2017 (the “Class Period”). Investors have until October 17, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On August 7, 2017, after the market had closed, Depomed di...
DEPOMED INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who ...
NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Depomed, Inc. (“Depomed” or the “Company”) (NASDAQ:DEPO) of the October 17, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Depomed stock or options between February 26, 2015 and August 7, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/DEPO. There is no cost or obligation to you. ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses...
NEW YORK--(BUSINESS WIRE)-- Pomerantz LLP announces that a class action lawsuit has been filed against Depomed, Inc. (“Depomed” or the “Company”) (NASDAQ:DEPO) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 17-cv-04830, is on behalf of a class consisting of investors who purchased or otherwise acquired Depomed securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934. ...
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has ...
NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Depomed, Inc. (NASDAQ:DEPO) securities between February 26, 2015 and August 7, 2017 (the “Class Period”). Investors have until October 17, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On August 7, 2017, after the market had closed, Depomed disclosed ...
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf...
NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Depomed, Inc. (NASDAQ: DEPO) who purchased shares between February 26, 2015 and August 7, 2017. The action, which was filed in the United States District Court for the Northern District of California, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or ...
DEPO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Depomed, Inc. ("Depomed") (NASDAQ: DEPO) securities between February 26, 2015 and August 7, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/depomed-inc?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company...
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Depomed, I...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Depomed, Inc. ("Depomed") (NASDAQ:DEPO) between February 26, 2015 and August 7, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information go to: http://www.zlk.com/plsra-c/depomed-inc?wire=2 or contact J...
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses i...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Depomed, Inc. (Nasdaq: DEPO) (“Depomed” or the “Company”) securities during the period between February 26, 2015 and August 7, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until October 17, 2017 to se...
The Klein Law Firm Announces a Class Action Filed on Behalf of Depomed...
NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Depomed, Inc. (NASDAQ: DEPO) who purchased shares between February 26, 2015 and August 7, 2017. The action, which was filed in the United States District Court for the Northern District of California, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or ...
DEPO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Inves...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Depomed, Inc. ("Depomed") (NASDAQ:DEPO) securities between February 26, 2015 and August 7, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/depomed-inc?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.